Phase I/II study exploring safety and efficacy of APL-101 plus frontline osimertinib in EGFR-mutated metastatic non-small cell lung cancer
APL-101;Osimertinib
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Phase I/II study exploring safety and efficacy of APL-101 plus frontline osimertinib in EGFR-mutated metastatic non-small cell lung cancer ### Output: APL-101;Osimertinib